This reversal might be associated to the 5-HT2 receptor antagonist action of MTZ, since this receptor is related to the development of SSRI-induced sexual dysfunction (Klint and Helsdingen 1996; Alcántara 1999; Zemishlany and Weizman 2008). Here, HTR2A is linked to sexual dysfunction.